Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05694572 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post-market Surveillance of Micorport CRM Cardiac Implantable Electronic Devices

Study acronym: PIANO
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 15, 2023 to Oct 30, 2023
    • Study sites: 0 to 1
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
MicroPort CRM
6 trials monitored
See all monitored trials
Heart Disease
8,786 trials monitored
See 412 trials at risk
Heart Failure
1,995 trials monitored
See 111 trials at risk
The primary objective of the study is to assess the chronic safety of MicroPort CRM market-released systems.
Trial Details
NCT Number NCT05694572
Lead Sponsor MicroPort CRM
Conditions
(from sponsor)		 Cardiac Rhythm Disorder, Heart Failure, Sudden Cardiac Death
Related terms Arrhythmias, Cardiac, Death, Sudden, Cardiac, Heart Failure
Enrollment 2,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov